INSR and diabetes mellitus: In this regard, the replacement with β-cells with IR overexpression could be a promising tool in the treatment of diabetes mellitus (DM), as long as the insulin receptor (IR)-overexpressing β-cells show similar functions and abilities as insulin through Wnt signaling.